Literature DB >> 9257363

Survival and cause of death among elderly chronic obstructive pulmonary disease patients after first admission to hospital.

S Vilkman1, T Keistinen, T Tuuponen, S L Kivelä.   

Abstract

Those patients with chronic obstructive pulmonary disease (COPD) who require hospital treatment are severely ill. We have studied the survival and cause of death among COPD patients in Finland after their first admission to hospital due to COPD. COPD-related treatment periods in all hospitals during 1972-1992 were collected from the national discharge register, and a subgroup was defined consisting of 2,237 patients aged 65-69 years who had their first admission during 1986-1990. Survival and causes of death were analysed for this group using the data contained in the national mortality statistics. The mortality data were recorded up to the end of 1993. By the end of 1993, 1,070 persons (48%) in the study group had died. The median survival time was 5.71 years (95% CI 5.27-6.15). Female COPD patients had a more favourable prognosis than males. COPD had been certified as the main cause of death for 33.3% of the women and 29.4% of the men. The proportion of COPD as main cause of death increased with an increasing number of treatment periods prior to death. In conclusion, the first hospital admission for COPD indicates a poor prognosis. A high incidence of pulmonary cancer contributes to the poor outcome in the case of men. COPD is obviously underrated on death certificates as the cause of death among COPD patients.

Entities:  

Mesh:

Year:  1997        PMID: 9257363     DOI: 10.1159/000196687

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  14 in total

1.  Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee.

Authors:  Lorcan P McGarvey; Matthias John; Julie A Anderson; Michael Zvarich; Robert A Wise
Journal:  Thorax       Date:  2007-02-20       Impact factor: 9.139

2.  COPD and death: what exactly is the relationship?

Authors:  Michael Rudolf
Journal:  Thorax       Date:  2007-05       Impact factor: 9.139

Review 3.  Palliative care in chronic obstructive pulmonary disease: a review for clinicians.

Authors:  David A Seamark; Clare J Seamark; David M G Halpin
Journal:  J R Soc Med       Date:  2007-05       Impact factor: 5.344

Review 4.  Comorbidities in chronic obstructive pulmonary disease.

Authors:  Wissam M Chatila; Byron M Thomashow; Omar A Minai; Gerard J Criner; Barry J Make
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 5.  Chronic obstructive pulmonary disease as a risk factor for lung cancer.

Authors:  Yuichi Takiguchi; Ikuo Sekine; Shunichiro Iwasawa; Ryota Kurimoto; Koichiro Tatsumi
Journal:  World J Clin Oncol       Date:  2014-10-10

6.  Clinical outcomes and cost analysis of exacerbations in chronic obstructive pulmonary disease.

Authors:  Marc Miravitlles; Cayo García-Polo; Adolfo Domenech; Gustavo Villegas; Francisco Conget; Cristian de la Roza
Journal:  Lung       Date:  2013-07-11       Impact factor: 2.584

7.  Sleep quality predicts quality of life in chronic obstructive pulmonary disease.

Authors:  Steven M Scharf; Nimrod Maimon; Tzahit Simon-Tuval; Barbara J Bernhard-Scharf; Haim Reuveni; Ariel Tarasiuk
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-12-22

8.  Effect of Perioperative β-Blockers on Pulmonary Complications among Patients with Chronic Obstructive Pulmonary Disease Undergoing Lung Resection Surgery.

Authors:  A Kamath; D E Stover; A Hemdan; I Belinskaya; R M Steingart; Y Taur; M B Feinstein
Journal:  Lung Cancer Int       Date:  2015-09-01

Review 9.  Changing the burden of COPD mortality.

Authors:  David M Mannino; Victor A Kiriz
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

10.  Genetic evidence linking lung cancer and COPD: a new perspective.

Authors:  Robert P Young; Raewyn J Hopkins; Gregory D Gamble; Carol Etzel; Randa El-Zein; James D Crapo
Journal:  Appl Clin Genet       Date:  2011-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.